Therapeutics: Spoilt for choice

Michael Eisenstein
Additional contact information
Michael Eisenstein: freelance science writer based in Philadelphia

Nature, 2017, vol. 551, issue 7679, S36-S38

Abstract: People with metastatic bladder cancer once faced meagre treatment options and a grim prognosis. But immunotherapy has started to yield results.

Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/551S36a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:551:y:2017:i:7679:d:10.1038_551s36a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/551S36a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().